缺血负荷变化对等待肾移植的终末期肾病患者结局的影响
回顾性队列纳入700例无症状等待肾移植的终末期肾病患者,均接受至少2次SPECT心肌灌注显像。两次显像间缺血负荷变化以ΔSDS≥2分定义;MPI1无缺血者中15%在MPI2出现新发缺血,与主要不良心血管事件风险升高相关(校正HR 1.75);MPI1有缺血者中66%缺血负荷改善,与主要不良心血管事件风险降低相关(校正HR 0.46);血运重建与缺血改善对结局无显著交互作用。
要点
- MPI1无缺血(SDS≤1)者中15%在MPI2出现新发缺血,与主要不良心血管事件风险升高相关(校正HR 1.75)。
- MPI1有缺血(SDS≥2)者中66%在MPI2缺血负荷改善,与主要不良心血管事件风险降低相关(校正HR 0.46)。
- 两次MPI间29例(4%)接受血运重建,血运重建与缺血改善对结局无显著交互作用(交互P=0.845)。
核心结论
- 在因冠心病监测接受系列MPI的肾移植候选者中,新发缺血与主要不良心血管事件风险升高相关。
- 缺血负荷改善与主要不良心血管事件风险降低相关,且不受冠状动脉血运重建状态影响。
研究设计与样本
- 回顾性队列研究,纳入700例无症状等待肾移植的终末期肾病患者,均有至少2次系列SPECT心肌灌注显像。
- 两次MPI间缺血负荷显著变化定义为ΔSDS≥2分;MPI2后平均随访19±12个月,观察心脏死亡或心肌梗死。
主要发现
- 两次MPI间29例(4%)接受冠状动脉血运重建,血运重建与MPI2缺血负荷降低发生率更高相关(31% vs 17%,P=0.049)。
- 冠状动脉血运重建与缺血负荷改善对结局无显著交互作用(交互P=0.845)。
关键数值与推荐
- 两次MPI间缺血负荷显著变化定义为ΔSDS≥2分。
- MPI1无缺血定义为SDS≤1;MPI1有缺血定义为SDS≥2。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In asymptomatic patients with end-stage renal disease (ESRD) wait-listed for kidney transplantation (KT), it is unclear whether a change in ischemic burden on serial surveillance SPECT myocardial perfusion imaging (MPI) impacts outcome. METHODS AND RESULTS: In a retrospective cohort of 700 asymptomatic KT candidates with ≥ 2 sequential SPECT-MPI studies, we defined a significant change in ischemic burden between MPIs as ΔSDS of ≥ 2 points. Patients were followed for mean 19 ± 12 months after MPI2 for cardiac death or myocardial infarction. Between MPIs, 29 (4%) subjects received coronary revascularization which was associated with a greater incidence of reduction in ischemic burden on MPI2 (31% vs. 17%, P = 0.049). Among 514 patients with no ischemia on MPI1 (SDS ≤ 1), 15% had new ischemia on MPI2 which was associated with increased MACE (adjusted HR 1.75; CI 1.02-3.01; P = 0.041). Among 186 patients with ischemia on MPI1 (SDS ≥ 2), 66% had improvement of ischemic burden on MPI2 which was associated with significantly lower MACE (adjusted HR 0.46; CI 0.25-0.82; P = 0.009). There was no significant interaction between coronary revascularization and improvement in ischemic burden impacting outcome (interaction P = 0.845). CONCLUSION: Among KT candidates who underwent serial MPI for CAD surveillance, new ischemia was associated with increased MACE risk. Improvement in ischemic burden was associated with lower MACE risk irrespective of coronary revascularization status.
引用
- Tottleben J, Torres A, Doukky R, et al. Impact of change of ischemic burden on the outcomes of ESRD patients awaiting kidney transplantation. J Nucl Cardiol. 2023. PMID: 37170063. doi:10.1007/s12350-023-03287-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。